Lista de obras -

5'UTR point substitutions and N-terminal truncating mutations of ANKRD26 in acute myeloid leukemia

artículo científico publicado en 2017

A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCR

artículo científico publicado en 2014

A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: retrospective analysis of 530 patients

artículo científico publicado en 2011

A single dose of Pegfilgrastim versus daily Filgrastim to evaluate the mobilization and the engraftment of autologous peripheral hematopoietic progenitors in malignant lymphoma patients candidate for high-dose chemotherapy

artículo científico publicado el 30 de octubre de 2010

Accuracy of Mobile Applications versus Wearable Devices in Long-Term Step Measurements

artículo científico publicado en 2020

Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients ⬇️

artículo científico publicado el 18 de mayo de 2012

Acute promyelocytic leukemia with amplification of PML-RARalpha rearrangement: clinical implications

scientific article published on 12 May 2008

Acute promyelocytic leukemias share cooperative mutations with other myeloid-leukemia subgroups

artículo científico

Adrenomedullin in the growth modulation and differentiation of acute myeloid leukemia cells.

artículo científico publicado en 2016

Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery

artículo científico publicado en 2018

Axitinib in Ponatinib-Resistant B-Cell Acute Lymphoblastic Leukemia Harboring a T315L Mutation

scientific article published on 20 December 2020

BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome

artículo científico publicado en 2009

Blinatumomab vs historic standard-of-care treatment for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukaemia

artículo científico publicado en 2020

Chlorambucil-rituximab as first-line therapy in patients affected by follicular non-Hodgkin's lymphoma: a retrospective single-centre study

artículo científico publicado en 2014

Chromosome instability and translocation t(11;18) in primary gastric marginal zone B-cell lymphoma of MALT-type

artículo científico publicado en 2007

Chronic myeloid leukemia stem cells

artículo científico publicado en 2019

Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy

artículo científico publicado en 2018

Clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 study).

scientific article published on 24 February 2014

Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia

artículo científico publicado en 2018

Concurrent chromothripsis events in a case of TP53 depleted acute myeloid leukemia with myelodysplasia-related changes

scientific article published on 12 June 2019

Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1

scientific article published on 14 January 2020

Correction: The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML

scientific article published on 16 January 2020

Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer?

artículo científico publicado en 2019

GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia

artículo científico publicado en 2019

Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21.

artículo científico publicado en 2010

Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML

scientific article published on 01 October 2019

Grading of Neuroendocrine Carcinomas: Correlation of Ga-PET/CT Scan with Tissue Biomarkers

artículo científico publicado en 2018

Heterogeneous self-tracked health and fitness data integration and sharing according to a linked open data approach

artículo científico publicado en 2021

Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors

artículo científico publicado en 2019

Identification of Two DNMT3A Mutations Compromising Protein Stability and Methylation Capacity in Acute Myeloid Leukemia

scientific article published on 30 October 2019

Identification of a novel large EPCAM-MSH2 duplication, concurrently with LOHs in chromosome 20 and X, in a family with Lynch syndrome

artículo científico publicado en 2019

Imatinib mesylate can induce complete molecular remission in FIP1L1-PDGFR-a positive idiopathic hypereosinophilic syndrome.

artículo científico publicado en 2004

Impact of age on the outcome of patients with chronic myeloid leukemia in late chronic phase: results of a phase II study of the GIMEMA CML Working Party

artículo científico publicado en 2007

Impact of minimal residual disease status in patients with relapsed/refractory acute lymphoblastic leukemia treated with inotuzumab ozogamicin in the phase III INO-VATE trial

scientific article published on 25 November 2019

Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia

artículo científico publicado en 2018

Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective study

artículo científico publicado en 2018

Leukemia cutis in a Ph+ ALL patient treated with ponatinib

artículo científico publicado en 2018

Long term outcome of Ph+ CML patients achieving complete cytogenetic remission with interferon based therapy moving from interferon to imatinib era

scientific article published on 01 February 2014

Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients

scientific article published on 16 May 2019

Loss of PALB2 predicts poor prognosis in acute myeloid leukemia and suggests novel therapeutic strategies targeting the DNA repair pathway

artículo científico publicado en 2021

Male Breast Cancer: Results of the Application of Multigene Panel Testing to an Italian Cohort of Patients

scientific article published on 30 April 2020

Minimal residual disease level predicts outcome in adults with Ph-negative B-precursor acute lymphoblastic leukemia

scientific article published on 01 December 2019

Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosis.

artículo científico publicado en 2015

Network integration of multi-tumour omics data suggests novel targeting strategies

artículo científico publicado en 2018

New generation anaplastic lymphoma kinase inhibitors

scientific article published on 01 November 2019

Nilotinib against high dose imatinib for salvage therapy of chronic myeloid leukaemia

article

Novel Agents for Acute Myeloid Leukemia

artículo científico publicado en 2018

Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma Model

artículo científico publicado en 2020

Novel and Rare Fusion Transcripts Involving Transcription Factors and Tumor Suppressor Genes in Acute Myeloid Leukemia

scientific article published on 05 December 2019

Opposite activation of the Hedgehog pathway in CD138+ plasma cells and CD138-CD19+ B cells identifies two subgroups of patients with multiple myeloma and different prognosis

artículo científico publicado en 2016

Ponatinib treatment in chronic myeloid leukemia cell lines targets aurora kinase A/FOXM1 axis

scientific article published on 28 January 2020

Population Pharmacokinetics of Glasdegib in Patients With Advanced Hematologic Malignancies and Solid Tumors

scientific article published on 25 November 2019

Presence or the emergence of a F317L BCR-ABL mutation may be associated with resistance to dasatinib in Philadelphia chromosome-positive leukemia

artículo científico publicado en 2006

Prevalence of Achromobacter xylosoxidans in pulmonary mucosa-associated lymphoid tissue lymphoma in different regions of Europe

artículo científico publicado en 2013

Prognostic implications of cytogenetics in adults with acute lymphoblastic leukemia treated with inotuzumab ozogamicin

artículo científico publicado en 2019

Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study

artículo científico publicado en 2020

Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial

scientific article published on 04 June 2019

RALE051: a novel established cell line of sporadic Burkitt lymphoma

artículo científico publicado en 2017

Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain

artículo científico publicado en 2007

Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes

scientific article published on 20 February 2019

Rituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03

artículo científico publicado en 2015

Ruxolitinib in elderly patients with myelofibrosis: impact of age and genotype. A multicentre study on 291 elderly patients

artículo científico publicado en 2018

SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis

artículo científico publicado en 2017

Secondary haematological malignancies after radioimmunotherapy ⬇️

artículo científico publicado el 11 de octubre de 2011

Single-Cell NGS-Based Analysis of Copy Number Alterations Reveals New Insights in Circulating Tumor Cells Persistence in Early-Stage Breast Cancer

scientific article published on 02 September 2020

Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1

scientific article published on 11 March 2019

Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia

scientific article published on 25 October 2019

Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107)

artículo científico publicado en 2011

Texture analysis in 177Lu SPECT phantom images: Statistical assessment of uniformity requirements using texture features

artículo científico publicado en 2019

The E3 ubiquitin ligase WWP1 sustains the growth of acute myeloid leukaemia

artículo científico publicado en 2017

The balance between mitotic death and mitotic slippage in acute leukemia: a new therapeutic window?

artículo científico publicado en 2019

The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome. Results of a multicenter prospective study

artículo científico publicado en 2007

The genetic and genomic background of multiple myeloma patients achieving complete response after induction therapy with bortezomib, thalidomide and dexamethasone (VTD)

artículo científico publicado en 2015

Unexpected low expression of platelet fibrinogen receptor in patients with chronic myeloproliferative neoplasms: how does it change with aspirin?

artículo científico publicado en 2019

Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes.

artículo científico publicado en 2009

Lista de obras de

5'UTR point substitutions and N-terminal truncating mutations of ANKRD26 in acute myeloid leukemia

A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCR

A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: retrospective analysis of 530 patients

A single dose of Pegfilgrastim versus daily Filgrastim to evaluate the mobilization and the engraftment of autologous peripheral hematopoietic progenitors in malignant lymphoma patients candidate for high-dose chemotherapy

Accuracy of Mobile Applications versus Wearable Devices in Long-Term Step Measurements

Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients ⬇️

Acute promyelocytic leukemia with amplification of PML-RARalpha rearrangement: clinical implications

Acute promyelocytic leukemias share cooperative mutations with other myeloid-leukemia subgroups

Adrenomedullin in the growth modulation and differentiation of acute myeloid leukemia cells.

Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery

Axitinib in Ponatinib-Resistant B-Cell Acute Lymphoblastic Leukemia Harboring a T315L Mutation

BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome

Blinatumomab vs historic standard-of-care treatment for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukaemia

Chlorambucil-rituximab as first-line therapy in patients affected by follicular non-Hodgkin's lymphoma: a retrospective single-centre study

Chromosome instability and translocation t(11;18) in primary gastric marginal zone B-cell lymphoma of MALT-type

Chronic myeloid leukemia stem cells

Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy

Clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 study).

Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia

Concurrent chromothripsis events in a case of TP53 depleted acute myeloid leukemia with myelodysplasia-related changes

Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1

Correction: The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML

Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer?

GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia

Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21.

Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML

Grading of Neuroendocrine Carcinomas: Correlation of Ga-PET/CT Scan with Tissue Biomarkers

Heterogeneous self-tracked health and fitness data integration and sharing according to a linked open data approach

Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors

Identification of Two DNMT3A Mutations Compromising Protein Stability and Methylation Capacity in Acute Myeloid Leukemia

Identification of a novel large EPCAM-MSH2 duplication, concurrently with LOHs in chromosome 20 and X, in a family with Lynch syndrome

Imatinib mesylate can induce complete molecular remission in FIP1L1-PDGFR-a positive idiopathic hypereosinophilic syndrome.

Impact of age on the outcome of patients with chronic myeloid leukemia in late chronic phase: results of a phase II study of the GIMEMA CML Working Party

Impact of minimal residual disease status in patients with relapsed/refractory acute lymphoblastic leukemia treated with inotuzumab ozogamicin in the phase III INO-VATE trial

Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia

Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective study

Leukemia cutis in a Ph+ ALL patient treated with ponatinib

Long term outcome of Ph+ CML patients achieving complete cytogenetic remission with interferon based therapy moving from interferon to imatinib era

Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients

Loss of PALB2 predicts poor prognosis in acute myeloid leukemia and suggests novel therapeutic strategies targeting the DNA repair pathway

Male Breast Cancer: Results of the Application of Multigene Panel Testing to an Italian Cohort of Patients

Minimal residual disease level predicts outcome in adults with Ph-negative B-precursor acute lymphoblastic leukemia

Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosis.

Network integration of multi-tumour omics data suggests novel targeting strategies

New generation anaplastic lymphoma kinase inhibitors

Nilotinib against high dose imatinib for salvage therapy of chronic myeloid leukaemia

Novel Agents for Acute Myeloid Leukemia

Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma Model

Novel and Rare Fusion Transcripts Involving Transcription Factors and Tumor Suppressor Genes in Acute Myeloid Leukemia

Opposite activation of the Hedgehog pathway in CD138+ plasma cells and CD138-CD19+ B cells identifies two subgroups of patients with multiple myeloma and different prognosis

Ponatinib treatment in chronic myeloid leukemia cell lines targets aurora kinase A/FOXM1 axis

Population Pharmacokinetics of Glasdegib in Patients With Advanced Hematologic Malignancies and Solid Tumors

Presence or the emergence of a F317L BCR-ABL mutation may be associated with resistance to dasatinib in Philadelphia chromosome-positive leukemia

Prevalence of Achromobacter xylosoxidans in pulmonary mucosa-associated lymphoid tissue lymphoma in different regions of Europe

Prognostic implications of cytogenetics in adults with acute lymphoblastic leukemia treated with inotuzumab ozogamicin

Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study

Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial

RALE051: a novel established cell line of sporadic Burkitt lymphoma

Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain

Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes

Rituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03

Ruxolitinib in elderly patients with myelofibrosis: impact of age and genotype. A multicentre study on 291 elderly patients

SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis

Secondary haematological malignancies after radioimmunotherapy ⬇️

Single-Cell NGS-Based Analysis of Copy Number Alterations Reveals New Insights in Circulating Tumor Cells Persistence in Early-Stage Breast Cancer

Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1

Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia

Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107)

Texture analysis in 177Lu SPECT phantom images: Statistical assessment of uniformity requirements using texture features

The E3 ubiquitin ligase WWP1 sustains the growth of acute myeloid leukaemia

The balance between mitotic death and mitotic slippage in acute leukemia: a new therapeutic window?

The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome. Results of a multicenter prospective study

The genetic and genomic background of multiple myeloma patients achieving complete response after induction therapy with bortezomib, thalidomide and dexamethasone (VTD)

Unexpected low expression of platelet fibrinogen receptor in patients with chronic myeloproliferative neoplasms: how does it change with aspirin?

Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes.